U.S. Food and Drug Administration (FDA) · United States
FDA Digital Promotion - Website and Social Media Requirements for Drugs/Devices
Requires company-owned digital promotion of Rx drugs and restricted devices to give the most serious risks alongside benefits, the established name, and access to full prescribing information.
21 U.S.C. 352(n); 21 CFR 202.1(b)(1), (e)(1), (e)(5)-(6); FDA Character Space Draft Guidance (2014)
What is FDA Digital Promotion - Website and Social Media Requirements for Drugs/Devices?
Requires company-owned digital promotion of Rx drugs and restricted devices to give the most serious risks alongside benefits, the established name, and access to full prescribing information. Apply to U.S. pharma and device websites, banner ads, paid search and company social posts that name a product and its use.
general_audience, general_adults_18plus, customers · Prescription Drug, Medical Device · pharma
Where does this rule apply?
United States
Which marketing channels are covered?
social_media, digital, website, display, search, video
When does this rule take effect?
2026-05-10
What does this rule require?
Requires company-owned digital promotion of Rx drugs and restricted devices to give the most serious risks alongside benefits, the established name, and access to full prescribing information.
How can marketing teams comply?
Apply to U.S. pharma and device websites, banner ads, paid search and company social posts that name a product and its use.
What is FDA Digital Promotion - Website and Social Media Requirements for Drugs/Devices?
Requires company-owned digital promotion of Rx drugs and restricted devices to give the most serious risks alongside benefits, the established name, and access to full prescribing information.
Who does this rule apply to?
general_audience, general_adults_18plus, customers · Prescription Drug, Medical Device · pharma
Where does this rule apply?
United States
Which marketing channels are covered?
social_media, digital, website, display, search, video
Requires DTC Rx ads to present the major risk statement clearly, conspicuously and neutrally, to provide adequate provision for full prescribing information in broadcast, and to include a brief summary in print.
Tobacco and nicotine ads must carry the required health warnings (20% of ad area for ENDS, cigars and smokeless), may not make light, mild or reduced-risk claims without an FDA modified-risk order, and may not offer free samples or appeal to youth.
FDA's food labeling rules require a Nutrition Facts panel and other label elements and restrict nutrient and 'healthy' claims to foods meeting FDA criteria; the amended 'healthy' definition is effective April 28, 2025 with compliance required by Feb. 25, 2028.
Supplements, cosmetics, foods and CBD products become unapproved drugs if their marketing claims to diagnose, treat, cure, mitigate or prevent disease, and cosmetics also may not claim to affect body structure or function.
OTC external drug products covered by 21 CFR 358 (warts, corns and calluses, ingrown toenails, lice, dandruff, seborrheic dermatitis, psoriasis) may only claim the uses and actives in their monograph.
FDA food additive rules require additives to be approved or GRAS, and labeling rules require certified colors and preservatives to be declared properly; 'no artificial' or 'no preservative' claims must match the ingredient list.
Request a free compliance scan of your homepage and book a time with Warrant.